Next week, two U.S. cannabis giants, Curaleaf and Trulieve, are set to follow in reporting earnings. While the sector is down ...

Ispire Technology stock slides post-IPO amid cannabis slump. Learn why ISPR remains a 'Sell' despite forecasts, risks, and sector challenges.